Skip to main content

Moxifloxacin

NDC 63323-850 · Fresenius Kabi USA, LLC

Generic nameMOXIFLOXACIN HYDROCHLORIDE

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)MOXIFLOXACIN HYDROCHLORIDE

Strength400 mg/250mL

Pharmacologic classFluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]

Marketing categoryNDA

Packages

63323-850-04 — 12 BAG in 1 CASE (63323-850-04) / 250 mL in 1 BAG (63323-850-74)

Billed under HCPCS

J2281 — Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg Medicare Part B payment limit (ASP + 6%): $6.64

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50090-6357 — Moxifloxacin, 50090-6609 — Moxifloxacin Hydrochloride, 50090-7244 — moxifloxacin hydrochloride, 50090-7665 — Moxifloxacin Hydrochloride, 50090-8029 — MOXIFLOXACIN, 50268-576 — Moxifloxacin Hydrochloride, 55111-112 — Moxifloxacin, 57237-156 — Moxifloxacin Hydrochloride, 62135-014 — Moxifloxacin, 62332-505 — Moxifloxacin ophthalmic solution, 63629-8357 — Moxifloxacin, 65862-603 — moxifloxacin hydrochloride, 65862-840 — MOXIFLOXACIN, 66298-8507 — MOXIFLOXACIN HYDROCHLORIDE, 67296-2222 — Moxifloxacin, 67296-2232 — Moxifloxacin Hydrochloride, 67457-323 — MOXIFLOXACIN HYDROCHLORIDE, 68083-210 — Moxifloxacin Ophthalmic, 68084-722 — Moxifloxacin Hydrochloride, 68180-421 — MOXIFLOXACIN, +25 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels